SlideShare uma empresa Scribd logo
1 de 52
Baixar para ler offline
Two	
  Unique	
  Approaches	
  
                   Dr.	
  Gary	
  Mar7n	
  
Homicide	
  Detec7ve,	
  Palm	
  Beach	
  County	
  (FL)	
  Sheriff’s	
  
                      Department	
  	
  

                          Jason	
  Parman	
  
            Assistant	
  U.S.	
  AJorney,	
  London,	
  KY	
  


                       April	
  2	
  –	
  4,	
  2013	
  
                     Omni	
  Orlando	
  Resort	
  	
  
                      at	
  ChampionsGate	
  
Lesson	
  Objec7ve	
  
1.  Outline	
  inves7ga7ve	
  priori7es	
  in	
  building	
  an	
  
    overdose	
  death	
  prosecu7on.	
  
2.  	
  State	
  the	
  benefit	
  of	
  building	
  strategic	
  
    coopera7on	
  between	
  federal	
  and	
  state	
  law	
  
    enforcement	
  agencies.	
  
3.  	
  Demonstrate	
  how	
  law	
  enforcement	
  can	
  work	
  
    together	
  with	
  community	
  preven7on	
  
    programs	
  in	
  inves7ga7ons.	
  
Overdose	
  Suppression	
  Project:	
  	
  
 A	
  Comprehensive	
  Response	
  
•  Law	
  Enforcement	
  

•  Public	
  Awareness	
  	
  

•  Quan6ta6ve	
  Research	
  
•  Reviewing	
  each	
  overdose	
  death	
  inves7ga7on.	
  	
  
•  Applying	
  all	
  relevant	
  statutes	
  to	
  the	
  
   circumstances.	
  
•  Forwarding	
  all	
  narco7cs	
  intelligence.	
  
•  19.3	
  %	
  of	
  the	
  case	
  reviews	
  generated	
  narco7cs	
  
   intelligence.	
  	
  	
  	
  
•  Overdose	
  and	
  poisoning	
  should	
  be	
  ruled	
  out	
  in	
  
   all	
  cases	
  of	
  non-­‐violent	
  deaths.	
  	
  
•    Scene	
  Inves7ga7on	
  
•    Physical	
  Examina7on	
  of	
  the	
  Decedent	
  
•    Autopsy	
  Results	
  
•    Toxicology	
  Findings	
  
If	
  a	
  person	
  dies	
  of	
  an	
  apparent	
  drug	
  overdose:	
  

(1)	
  A	
  law	
  enforcement	
  agency	
  shall	
  prepare	
  a	
  report	
  iden7fying	
  each	
  
                    prescribed	
  controlled	
  substance	
  listed	
  in	
  Schedule	
  II,	
  Schedule	
  III,	
  or	
  
                    Schedule	
  IV	
  of	
  s.	
  893.03	
  which	
  is	
  found	
  on	
  or	
  near	
  the	
  deceased	
  or	
  among	
  
                    the	
  deceased's	
  possessions.	
  The	
  report	
  must	
  iden7fy	
  the	
  person	
  who	
  
                    prescribed	
  the	
  controlled	
  substance,	
  if	
  known	
  or	
  ascertainable.	
  Thereaeer,	
  
                    the	
  law	
  enforcement	
  agency	
  shall	
  submit	
  a	
  copy	
  of	
  the	
  report	
  to	
  the	
  
                    medical	
  examiner.	
  (2)	
  A	
  medical	
  examiner	
  who	
  is	
  preparing	
  a	
  report	
  
                    pursuant	
  to	
  s.	
  406.11	
  shall	
  include	
  in	
  the	
  report	
  informa7on	
  iden7fying	
  
                    each	
  prescribed	
  controlled	
  substance	
  listed	
  in	
  Schedule	
  II,	
  Schedule	
  III,	
  or	
  
                    Schedule	
  IV	
  of	
  s.	
  893.03	
  that	
  was	
  found	
  in,	
  on,	
  or	
  near	
  the	
  deceased	
  or	
  
                    among	
  the	
  deceased's	
  
	
  	
  	
  	
  	
  possessions.	
  
•  All	
  prescrip6on	
  drug	
  containers	
  (including	
  empty	
  containers)	
  should	
  be	
  
   photographed,	
  seized,	
  and	
  then	
  individually	
  described	
  on	
  a	
  property	
  
   receipt.	
  	
  

•  All	
  unfilled	
  prescrip6on	
  authoriza6ons	
  “scripts”	
  should	
  be	
  
   photographed,	
  seized,	
  and	
  individually	
  described	
  on	
  a	
  property	
  receipt.	
  

•  All	
  illegal	
  drug	
  containers	
  (plas6c	
  baggies,	
  film	
  vials,	
  e.t.c.)	
  should	
  be	
  
   handled	
  in	
  such	
  a	
  way	
  that	
  poten6al	
  trace	
  evidence	
  could	
  be	
  extracted.	
  

•  Within	
  reason,	
  samples	
  of	
  drinking	
  fluids	
  discovered	
  within	
  the	
  
   immediate	
  area	
  of	
  the	
  suspected	
  overdose	
  death	
  should	
  be	
  collected.	
  	
  
Evaluate	
  physical	
  evidence	
  of	
  prescrip7on	
  drug	
  abuse	
  and	
  
   diversion	
  by	
  the	
  decedent:	
  	
  
•  Appointment	
  cards	
  
•  Address/phone	
  books	
  	
  
•  Cell	
  phones/caller	
  id	
  	
  
•  Personal	
  computers	
  	
  	
  
•  Calendars	
  
•  Prescrip7on	
  vials	
  	
  
•  Unfilled	
  scripts	
  	
  
•  Pharmacy	
  receipts	
  
•  Drug	
  warning	
  documents	
  	
  
•  Forging	
  coopera6ve	
  rela6onships	
  with	
  families	
  who	
  have	
  
   lost	
  loved	
  ones	
  to	
  drug	
  overdose	
  death.	
  

•  Providing	
  overdose	
  risk	
  awareness	
  programs	
  to	
  students	
  
   and	
  parents.	
  

•  Designing	
  a	
  mul6media	
  public	
  service	
  	
  campaign	
  focusing	
  
   on	
  the	
  risks	
  associated	
  with	
  prescrip6on	
  drug	
  misuse	
  and	
  
   abuse.	
  

•  Seeking	
  legisla6ve	
  ac6on	
  to	
  discourage	
  doctor	
  shopping	
  
   and	
  prescrip6on	
  drug	
  diversion.	
  	
  	
  
“All	
  Bets	
  Are	
  Off”	
  	
  
The	
  Cri7cal	
  Point	
  
Ineffec7ve	
  Remedies	
  
•  Do	
  NOT	
  put	
  them	
  in	
  an	
  ice	
  cold	
  bath.	
  
•  Do	
  NOT	
  inject	
  them	
  with	
  salt	
  water	
  or	
  milk.	
  
•  Do	
  NOT	
  give	
  them	
  s7mulants	
  (like	
  cocaine,	
  
   methamphetamine,	
  or	
  Adderall).	
  
•  Do	
  NOT	
  give	
  them	
  food	
  or	
  water	
  or	
  induce	
  vomi7ng	
  
   (they	
  could	
  choke)	
  
•  Do	
  NOT	
  leave	
  them	
  alone.	
  
•  If	
  you	
  must	
  leave,	
  call	
  911	
  first	
  and	
  leave	
  them	
  in	
  the	
  
   recovery	
  posi7on.	
  
Recovery	
  Posi7on	
  
•  A	
  Drug	
  Overdose	
  Interven7on	
  Strategy.	
  	
  

•  Offers-­‐limited	
  immunity	
  from	
  criminal	
  prosecu7on	
  
   for	
  person(s)	
  who,	
  in	
  good	
  faith,	
  seek	
  medical	
  
   aJen7on	
  during	
  a	
  drug-­‐related	
  medical	
  crisis.	
  	
  

•  Intent-­‐reduce	
  the	
  number	
  of	
  drug	
  overdose	
  deaths	
  
   by	
  removing	
  the	
  fear	
  of	
  arrest	
  as	
  a	
  barrier	
  to	
  seeking	
  
   emergency	
  medical	
  assistance.	
  	
  	
  
911	
  Good	
  Samaritan	
  	
  
                   893.21	
  Drug-­‐related	
  overdoses;	
  medical	
  assistance;	
  immunity	
  from	
  
                                                     prosecu6on.	
  

•    (1)	
  A	
  person	
  ac7ng	
  in	
  good	
  faith	
  who	
  seeks	
  medical	
  assistance	
  for	
  an	
  individual	
  
     experiencing	
  a	
  drug-­‐related	
  overdose	
  may	
  not	
  be	
  charged,	
  prosecuted,	
  or	
  
     penalized	
  pursuant	
  to	
  this	
  chapter	
  for	
  possession	
  of	
  a	
  controlled	
  substance	
  if	
  the	
  
     evidence	
  for	
  possession	
  of	
  a	
  controlled	
  substance	
  was	
  obtained	
  as	
  a	
  result	
  of	
  the	
  
     person’s	
  seeking	
  medical	
  assistance.	
  
•    (2)	
  A	
  person	
  who	
  experiences	
  a	
  drug-­‐related	
  overdose	
  and	
  is	
  in	
  need	
  of	
  medical	
  
     assistance	
  may	
  not	
  be	
  charged,	
  prosecuted,	
  or	
  penalized	
  pursuant	
  to	
  this	
  chapter	
  
     for	
  possession	
  of	
  a	
  controlled	
  substance	
  if	
  the	
  evidence	
  for	
  possession	
  of	
  a	
  
     controlled	
  substance	
  was	
  obtained	
  as	
  a	
  result	
  of	
  the	
  overdose	
  and	
  the	
  need	
  for	
  
     medical	
  assistance.	
  
•    (3)	
  Protec7on	
  in	
  this	
  sec7on	
  from	
  prosecu7on	
  for	
  possession	
  offenses	
  under	
  this	
  
     chapter	
  may	
  not	
  be	
  grounds	
  for	
  suppression	
  of	
  evidence	
  in	
  other	
  criminal	
  
     prosecu7ons.	
  
•    This	
  act	
  shall	
  take	
  effect	
  October	
  1,	
  2012.	
  
•  Collec7ng	
  extensive	
  demographic	
  and	
  
   circumstan7al	
  data	
  from	
  each	
  overdose	
  death	
  
   inves7ga7on.	
  
•  Designing	
  a	
  prac7cal	
  overdose	
  death	
  
   database.	
  
•  	
  Exposing	
  overdose	
  correla7ons	
  and	
  trends.	
  	
  
Case	
  Examina6ons	
  	
  	
  	
  	
  
•    353	
  overdose	
  death	
  cases	
  
•    Palm	
  Beach	
  County,	
  Florida	
  	
  
•    Selected	
  by	
  chronological	
  occurrence	
  	
  
•    Data	
  derived	
  from:	
  
    Police	
  and	
  paramedic	
  reports	
  	
  	
  
    Autopsy	
  and	
  toxicology	
  findings	
  
    Family	
  and	
  friend	
  interviews	
  	
  
    Medical	
  records	
  	
  	
  	
  
Decedents’	
  Average	
  Age	
  




 40.08	
  Years	
  
•  Age	
  breakdown	
  	
  
•  White	
  
•  Male	
  
•  Approximately	
  40	
  years	
  old	
  
•  High	
  School	
  Diploma	
  or	
  GED	
  
•  Employed	
  
•  History	
  of	
  substance	
  abuse	
  
•  History	
  of	
  drug	
  related	
  arrests	
  
•  History	
  of	
  substance	
  abuse	
  treatment	
  
•  History	
  of	
  mental	
  health	
  treatment	
  
•  History	
  of	
  non	
  fatal	
  drug	
  overdose	
  
•  Under	
  physician’s	
  care	
  at	
  7me	
  of	
  death	
  
•    Died	
  at	
  home	
  
•    Discovered	
  by	
  family	
  member	
  
•    Last	
  act	
  is	
  sleeping	
  
•    Found	
  unconscious	
  
•    Others	
  present	
  at	
  death	
  scene	
  
•    Other	
  recognized	
  distress	
  
•    Died	
  from	
  accidental	
  mul7ple	
  drug	
  toxicity	
  
•    Most	
  likely	
  combina7ons	
  are	
  alprazolam,	
  
     oxycodone,	
  cocaine,	
  and	
  methadone.	
  
Detec7ve	
  Gary	
  Mar7n	
  	
  
Violent	
  Crimes	
  Division	
  –	
  Homicide	
  Unit	
  
Palm	
  Beach	
  County	
  Sheriff’s	
  Office	
  	
  
West	
  Palm	
  Beach,	
  Fl	
  33406	
  
561-­‐688-­‐4058	
  
mar7ng@pbso.org	
  

Or	
  	
  

Gary	
  Mar7n,	
  Ed.D.	
  
Associate	
  Dean	
  For	
  Student	
  Life	
  
Lynn	
  University	
  	
  
Boca	
  Raton,	
  Fl	
  33431	
  
561-­‐237-­‐7157	
  
gmar7n@lynn.edu	
  	
  
Two	
  Unique	
  Approaches	
  

       April	
  2	
  –	
  4,	
  2013	
  
     Omni	
  Orlando	
  Resort	
  	
  
      at	
  ChampionsGate	
  
Learning	
  Objec6ves	
  
•  1.	
  	
  Outline	
  inves7ga7ve	
  priori7es	
  in	
  building	
  an	
  	
  	
  	
  	
  	
  
   	
  	
  	
  	
  	
  overdose	
  death	
  prosecu7on.	
  

•  2.	
  	
  State	
  the	
  benefit	
  of	
  building	
  strategic	
   	
   	
   	
  	
  	
  
   	
  	
  	
  	
  	
  coopera7on	
  between	
  federal	
  and	
  state	
  law	
   	
  	
  	
  	
  
   	
  	
  	
  	
  	
  enforcement	
  agencies.	
  

•  3.	
  	
  Demonstrate	
  how	
  law	
  enforcement	
  can	
  work	
  
   	
  	
  	
  	
  	
  together	
  with	
  community	
  preven7on	
  	
  	
  	
  	
  	
  	
   	
  	
  	
  	
  	
  	
  	
  
   	
  	
  	
  	
  	
  programs	
  in	
  inves7ga7ons.	
  
Disclosure	
  Statement	
  
Controlled	
  Substances	
  Act	
  covers	
  
                     overdose	
  deaths	
  
21	
  USC	
  841(A)(1):	
                    	
  1.	
  Knowing	
  distribu7on	
  of	
  controlled	
  
      	
   	
   	
   	
   	
                 	
   	
  	
  	
  	
  	
  	
  substance	
  	
  

      	
       	
      	
      	
     	
     	
  2.	
  Death	
  results	
  from	
  use	
  of	
  controlled	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
      	
       	
      	
      	
     	
     	
  	
  	
  	
  	
  substance	
  

	
  	
  	
  21	
  USC	
  846:	
       	
  	
  	
  	
  	
  	
  	
  1.	
  Two	
  or	
  more	
  people	
  must	
  conspire	
  to	
  	
  
             	
   	
   	
   	
        	
   	
  	
  	
  	
  	
  distribute	
  a	
  controlled	
  substance	
  

      	
       	
      	
      	
     	
     	
  2.	
  Death	
  results	
  from	
  use	
  of	
  controlled	
  
      	
       	
      	
      	
     	
     	
   	
  	
  	
  	
  	
  	
  substance	
  
Inves7ga7ve	
  Priori7es	
  
          What caused the death?                                                         Who did it?

•    Medical	
  examiner’s	
  report	
  essen7al	
  –	
               •  Witnesses	
  who	
  observed	
  drug	
  
     work	
  to	
  develop	
  rela7onships	
  with	
                     distribu7on	
  to	
  the	
  deceased?	
  
     coroners	
  
                                                                      •  For	
  prescrip7on	
  overdoses,	
  tracking	
  the	
  
•    Toxicology	
  report	
  helpful,	
  but	
  not	
  
     disposi7ve	
                                                        paper	
  trail	
  is	
  useful	
  
•    Do	
  NOT	
  have	
  to	
  prove	
  intent	
  to	
  kill,	
      •  Standard	
  drug	
  inves7ga7ons	
  is	
  
     recklessness,	
  foreseeability,	
  or	
  other	
                   important	
  parallel	
  
     mental	
  state	
  rela7ve	
  to	
  the	
  death	
  	
  
•    The	
  element	
  that	
  must	
  be	
  proven	
  is	
  
     “Did	
  death	
  result	
  from	
  the	
  use	
  of	
  the	
  
     controlled	
  substance?”	
  
•    Distributed	
  drug	
  does	
  not	
  have	
  to	
  be	
  
     exclusive	
  or	
  primary	
  cause	
  of	
  death,	
  
     only	
  had	
  to	
  have	
  played	
  a	
  part.	
  
“Tradi7onal”	
  TARGETS	
  
     Sponsors,	
  Brokers,	
  Direct	
  Distributors	
  

•  Developing	
  sources	
  of	
  
   informa7on	
  /	
  cooperators	
  key	
  	
  
•  Establish	
  rela7onships	
  between	
  
   targets	
  rela7ve	
  to	
  date	
  of	
  
   distribu7on	
  
•  Was	
  target	
  in	
  the	
  chain	
  of	
  
   distribu7on	
  that	
  led	
  to	
  the	
  death	
  
•  Tracking	
  the	
  line	
  from	
  the	
  end	
  
   user	
  to	
  the	
  drug	
  source	
  reveals	
  
   poten7al	
  targets	
  	
  (All	
  in	
  the	
  chain	
  
   are	
  poten7al	
  defendants	
  as	
  long	
  
   as	
  distribu7on	
  to	
  end	
  user	
  	
  was	
  
   reasonably	
  foreseeable)	
  
 POTENTIAL	
  TARGETS	
  
       Doctors	
  /	
  Pharmacists	
  

•  Need	
  to	
  show	
  target	
  prescribed	
  /	
  
   filled	
  medica7on	
  without	
  legi7mate	
  
   medical	
  purpose	
  outside	
  the	
  usual	
  
   course	
  of	
  professional	
  treatment	
  	
  
•  PaJern	
  of	
  pa7ents	
  help	
  to	
  establish	
  
   unlawful	
  distribu7on	
  	
  
•  Cash	
  only	
  clientele	
  
•  Superficial	
  examina7ons	
  
•  Expert	
  review	
  of	
  records	
  
•  Cooperators	
  beneficial	
  
•  Conspiratorial	
  rela7onship	
  between	
  
   providers	
  (warning	
  pa7ents	
  where	
  
   to	
  or	
  not	
  to	
  fill	
  scripts)	
  
“Death	
  Resul7ng”	
  Penal7es	
  
                           	
  Statutory	
  Penal6es	
                           Sentencing	
  Guidelines	
  
              	
  	
  	
  21	
  USC	
  841(b)(1)(A)-­‐(C)	
                         U.S.S.G.	
  §	
  2D1.1	
  

•  Mandatory	
  Minimum	
  20	
  years	
                        •  Deaths	
  from	
  Schedule	
  I	
  or	
  II	
  with	
  prior	
  
   with	
  Life	
  max	
                                           convic7on	
  for	
  trafficking	
  with	
  similar	
  
                                                                   drug	
  is	
  43	
  (360	
  –	
  life)	
  
•  Applies	
  to	
  all	
  Schedule	
  I	
  and	
  II	
  
                                                                •  No	
  prior	
  convic7on	
  is	
  38	
  (235-­‐293)	
  
   Controlled	
  Substances	
  
   (oxycodone,	
  methadone,	
  etc.)	
                         •  Deaths	
  from	
  Schedule	
  III	
  and	
  IV	
  (ie:	
  
                                                                   hydrocodone,	
  alprazolam)	
  start	
  at	
  30	
  
                                                                   (97-­‐121)	
  with	
  prior	
  convic7on	
  and	
  26	
  
                                                                   (63-­‐78)	
  without	
  convic7on	
  
                                                                •  All	
  ranges	
  assume	
  no	
  criminal	
  history	
  
                                                                •  Ex:	
  Criminal	
  History	
  I	
  with	
  a	
  38	
  
                                                                   (235-­‐293)	
  is	
  (360	
  to	
  life)	
  with	
  a	
  
                                                                   Criminal	
  History	
  VI	
  
United	
  States	
  v.	
  McIntosh	
  
      DEA	
  inves6ga6on	
  with	
  State	
  	
  
                partnerships	
                                                       Result	
  ?	
  

•    What	
  made	
  it	
  work?	
                                •  McIntosh	
  sentenced	
  to	
  327	
  
•    First	
  responders	
  treated	
  call	
  as	
  a	
             months	
  for	
  distribu7on	
  resul7ng	
  
     crime	
  scene	
  vs.	
  an	
  accident	
  	
                   in	
  death	
  (guideline	
  range	
  of	
  
•    Autopsy	
  that	
  established	
  oxycodone	
                   292-­‐327)	
  Lowest	
  criminal	
  history	
  
     as	
  a	
  contribu7ng	
  factor	
  in	
  the	
  death	
        category	
  
•    DEA	
  later	
  implicated	
  McIntosh	
  in	
  a	
                 Who	
  collaborated?	
  
     large	
  oxycodone	
  conspiracy	
  through	
                •    Kentucky	
  State	
  Police	
  
     cooperator	
  statements	
  and	
  local	
  law	
  
                                                                  •    Local	
  Law	
  Enforcement	
  
     enforcement’s	
  street	
  level	
  buys	
  	
  
•    Crucial	
  leads	
  in	
  the	
  inves7ga7ve	
               •    County	
  Coroner	
  
     report	
  from	
  10	
  months	
  prior	
                    •    State	
  Medical	
  Examiner	
  
•    Knew	
  the	
  Who,	
  What,	
  When	
  and	
                •    DEA	
  
     Where	
  and	
  it	
  was	
  documented	
  
Benefits	
  to	
  “death	
  resul7ng”	
  
                        prosecu7ons	
  
         “Tradi6onal”	
  Drug	
  Dealers	
  	
                              “Professional”	
  Drug	
  Dealers	
  

•    Dealing	
  is	
  ul7mately	
  a	
  decision	
                  •    Doctors,	
  Pharmacists,	
  etc.	
  
•    “The	
  nega7ve	
  has	
  to	
  outweigh	
  the	
              •    Enormous	
  profit	
  margins	
  for	
  pain	
  clinic	
  
     posi7ve”	
                                                          owners,	
  doctors,	
  pharmacists	
  
•    Reality	
  is	
  Rx	
  diversion	
  is	
  a	
  profitable	
     •    $100,000	
  cash	
  in	
  one	
  day,	
  for	
  example	
  
     revenue	
  plan	
  for	
  many	
                               •    Violate	
  your	
  duty,	
  responsible	
  for	
  the	
  
•    These	
  prosecu7ons	
  send	
  a	
  simple,	
                      consequence	
  
     powerful	
  message	
  	
                                      •    Given	
  the	
  harm	
  produced	
  from	
  
                                                                         prescrip7on	
  diversion,	
  must	
  target	
  
•    Distribute	
  prescrip7on	
  drugs,	
  you	
  will	
  
                                                                         those	
  with	
  “keys	
  to	
  the	
  castle”	
  
     be	
  held	
  responsible	
  for	
  the	
  
                                                                    •    Treats	
  the	
  source	
  =	
  to	
  a	
  drug	
  dealer	
  
     consequence	
  	
  
Ques7ons/Comments	
  

       Jason	
  D.	
  Parman	
  
United	
  States	
  AJorneys	
  Office	
  
 Eastern	
  District	
  of	
  Kentucky	
  
   606-­‐864-­‐5523	
  	
  Ext.	
  117	
  
  Jason.Parman@usdoj.gov	
  

Mais conteúdo relacionado

Destaque

Roger West
Roger WestRoger West
Roger WestOPUNITE
 
A tale of_2_companies_final
A tale of_2_companies_finalA tale of_2_companies_final
A tale of_2_companies_finalOPUNITE
 
Enabling and intervention_final
Enabling and intervention_finalEnabling and intervention_final
Enabling and intervention_finalOPUNITE
 
Len 3 joint presentation
Len 3 joint presentationLen 3 joint presentation
Len 3 joint presentationOPUNITE
 
Treatment options for_juveniles_final
Treatment options for_juveniles_finalTreatment options for_juveniles_final
Treatment options for_juveniles_finalOPUNITE
 
Samhs as tools_for_treatment
Samhs as tools_for_treatmentSamhs as tools_for_treatment
Samhs as tools_for_treatmentOPUNITE
 
Rob Morrison
Rob MorrisonRob Morrison
Rob MorrisonOPUNITE
 

Destaque (7)

Roger West
Roger WestRoger West
Roger West
 
A tale of_2_companies_final
A tale of_2_companies_finalA tale of_2_companies_final
A tale of_2_companies_final
 
Enabling and intervention_final
Enabling and intervention_finalEnabling and intervention_final
Enabling and intervention_final
 
Len 3 joint presentation
Len 3 joint presentationLen 3 joint presentation
Len 3 joint presentation
 
Treatment options for_juveniles_final
Treatment options for_juveniles_finalTreatment options for_juveniles_final
Treatment options for_juveniles_final
 
Samhs as tools_for_treatment
Samhs as tools_for_treatmentSamhs as tools_for_treatment
Samhs as tools_for_treatment
 
Rob Morrison
Rob MorrisonRob Morrison
Rob Morrison
 

Semelhante a Two unique approaches_final

Role of toxicology findings and drug Recognition expert
Role of toxicology findings and drug Recognition expertRole of toxicology findings and drug Recognition expert
Role of toxicology findings and drug Recognition expertHoneyM4
 
Forensic Toxicology.pptx
Forensic Toxicology.pptxForensic Toxicology.pptx
Forensic Toxicology.pptxsamirich1
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerOPUNITE
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasOPUNITE
 
Rx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonRx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonOPUNITE
 
The management of drug misusers in custody (1)
The management of drug misusers in custody (1)The management of drug misusers in custody (1)
The management of drug misusers in custody (1)Michael Gregory
 
New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?Julian Buchanan
 
Medication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. KannenbergMedication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. KannenbergRand Kannenberg
 
Vernon Stejskal
Vernon StejskalVernon Stejskal
Vernon StejskalOPUNITE
 
Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gayOPUNITE
 
2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarusprofcyclist
 
Web only rx16 len-tues_330_1_kougasian-sakacs_2niedermann
Web only rx16 len-tues_330_1_kougasian-sakacs_2niedermannWeb only rx16 len-tues_330_1_kougasian-sakacs_2niedermann
Web only rx16 len-tues_330_1_kougasian-sakacs_2niedermannOPUNITE
 
Are you following_the_script may 2015
Are you following_the_script may 2015Are you following_the_script may 2015
Are you following_the_script may 2015Polsinelli PC
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyOPUNITE
 
Importance of forensic lab in pharmacy
Importance of forensic lab in pharmacyImportance of forensic lab in pharmacy
Importance of forensic lab in pharmacyM Habib
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickOPUNITE
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_naderOPUNITE
 
CDC 2018-Evidence-Based-Strategies For Preventing Opioid Overdose
CDC 2018-Evidence-Based-Strategies For Preventing Opioid OverdoseCDC 2018-Evidence-Based-Strategies For Preventing Opioid Overdose
CDC 2018-Evidence-Based-Strategies For Preventing Opioid OverdoseCassondra Turner McArthur
 

Semelhante a Two unique approaches_final (20)

Role of toxicology findings and drug Recognition expert
Role of toxicology findings and drug Recognition expertRole of toxicology findings and drug Recognition expert
Role of toxicology findings and drug Recognition expert
 
Forensic Toxicology.pptx
Forensic Toxicology.pptxForensic Toxicology.pptx
Forensic Toxicology.pptx
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
 
aidslinedec13
aidslinedec13aidslinedec13
aidslinedec13
 
Rx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonRx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethington
 
The management of drug misusers in custody (1)
The management of drug misusers in custody (1)The management of drug misusers in custody (1)
The management of drug misusers in custody (1)
 
New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?New Zealand Drug Courts: Driven by ideology or evidence?
New Zealand Drug Courts: Driven by ideology or evidence?
 
Medication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. KannenbergMedication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. Kannenberg
 
Vernon Stejskal
Vernon StejskalVernon Stejskal
Vernon Stejskal
 
ERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose PatientsERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose Patients
 
Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gay
 
2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus2/12/2015 - Project Lazarus
2/12/2015 - Project Lazarus
 
Web only rx16 len-tues_330_1_kougasian-sakacs_2niedermann
Web only rx16 len-tues_330_1_kougasian-sakacs_2niedermannWeb only rx16 len-tues_330_1_kougasian-sakacs_2niedermann
Web only rx16 len-tues_330_1_kougasian-sakacs_2niedermann
 
Are you following_the_script may 2015
Are you following_the_script may 2015Are you following_the_script may 2015
Are you following_the_script may 2015
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 
Importance of forensic lab in pharmacy
Importance of forensic lab in pharmacyImportance of forensic lab in pharmacy
Importance of forensic lab in pharmacy
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_nader
 
CDC 2018-Evidence-Based-Strategies For Preventing Opioid Overdose
CDC 2018-Evidence-Based-Strategies For Preventing Opioid OverdoseCDC 2018-Evidence-Based-Strategies For Preventing Opioid Overdose
CDC 2018-Evidence-Based-Strategies For Preventing Opioid Overdose
 

Mais de OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 

Mais de OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Two unique approaches_final

  • 1. Two  Unique  Approaches   Dr.  Gary  Mar7n   Homicide  Detec7ve,  Palm  Beach  County  (FL)  Sheriff’s   Department     Jason  Parman   Assistant  U.S.  AJorney,  London,  KY   April  2  –  4,  2013   Omni  Orlando  Resort     at  ChampionsGate  
  • 2. Lesson  Objec7ve   1.  Outline  inves7ga7ve  priori7es  in  building  an   overdose  death  prosecu7on.   2.   State  the  benefit  of  building  strategic   coopera7on  between  federal  and  state  law   enforcement  agencies.   3.   Demonstrate  how  law  enforcement  can  work   together  with  community  preven7on   programs  in  inves7ga7ons.  
  • 3.
  • 4.
  • 5.
  • 6. Overdose  Suppression  Project:     A  Comprehensive  Response  
  • 7. •  Law  Enforcement   •  Public  Awareness     •  Quan6ta6ve  Research  
  • 8. •  Reviewing  each  overdose  death  inves7ga7on.     •  Applying  all  relevant  statutes  to  the   circumstances.   •  Forwarding  all  narco7cs  intelligence.   •  19.3  %  of  the  case  reviews  generated  narco7cs   intelligence.        
  • 9. •  Overdose  and  poisoning  should  be  ruled  out  in   all  cases  of  non-­‐violent  deaths.    
  • 10. •  Scene  Inves7ga7on   •  Physical  Examina7on  of  the  Decedent   •  Autopsy  Results   •  Toxicology  Findings  
  • 11. If  a  person  dies  of  an  apparent  drug  overdose:   (1)  A  law  enforcement  agency  shall  prepare  a  report  iden7fying  each   prescribed  controlled  substance  listed  in  Schedule  II,  Schedule  III,  or   Schedule  IV  of  s.  893.03  which  is  found  on  or  near  the  deceased  or  among   the  deceased's  possessions.  The  report  must  iden7fy  the  person  who   prescribed  the  controlled  substance,  if  known  or  ascertainable.  Thereaeer,   the  law  enforcement  agency  shall  submit  a  copy  of  the  report  to  the   medical  examiner.  (2)  A  medical  examiner  who  is  preparing  a  report   pursuant  to  s.  406.11  shall  include  in  the  report  informa7on  iden7fying   each  prescribed  controlled  substance  listed  in  Schedule  II,  Schedule  III,  or   Schedule  IV  of  s.  893.03  that  was  found  in,  on,  or  near  the  deceased  or   among  the  deceased's            possessions.  
  • 12. •  All  prescrip6on  drug  containers  (including  empty  containers)  should  be   photographed,  seized,  and  then  individually  described  on  a  property   receipt.     •  All  unfilled  prescrip6on  authoriza6ons  “scripts”  should  be   photographed,  seized,  and  individually  described  on  a  property  receipt.   •  All  illegal  drug  containers  (plas6c  baggies,  film  vials,  e.t.c.)  should  be   handled  in  such  a  way  that  poten6al  trace  evidence  could  be  extracted.   •  Within  reason,  samples  of  drinking  fluids  discovered  within  the   immediate  area  of  the  suspected  overdose  death  should  be  collected.    
  • 13. Evaluate  physical  evidence  of  prescrip7on  drug  abuse  and   diversion  by  the  decedent:     •  Appointment  cards   •  Address/phone  books     •  Cell  phones/caller  id     •  Personal  computers       •  Calendars   •  Prescrip7on  vials     •  Unfilled  scripts     •  Pharmacy  receipts   •  Drug  warning  documents    
  • 14.
  • 15.
  • 16.
  • 17. •  Forging  coopera6ve  rela6onships  with  families  who  have   lost  loved  ones  to  drug  overdose  death.   •  Providing  overdose  risk  awareness  programs  to  students   and  parents.   •  Designing  a  mul6media  public  service    campaign  focusing   on  the  risks  associated  with  prescrip6on  drug  misuse  and   abuse.   •  Seeking  legisla6ve  ac6on  to  discourage  doctor  shopping   and  prescrip6on  drug  diversion.      
  • 18. “All  Bets  Are  Off”    
  • 20. Ineffec7ve  Remedies   •  Do  NOT  put  them  in  an  ice  cold  bath.   •  Do  NOT  inject  them  with  salt  water  or  milk.   •  Do  NOT  give  them  s7mulants  (like  cocaine,   methamphetamine,  or  Adderall).   •  Do  NOT  give  them  food  or  water  or  induce  vomi7ng   (they  could  choke)   •  Do  NOT  leave  them  alone.   •  If  you  must  leave,  call  911  first  and  leave  them  in  the   recovery  posi7on.  
  • 22. •  A  Drug  Overdose  Interven7on  Strategy.     •  Offers-­‐limited  immunity  from  criminal  prosecu7on   for  person(s)  who,  in  good  faith,  seek  medical   aJen7on  during  a  drug-­‐related  medical  crisis.     •  Intent-­‐reduce  the  number  of  drug  overdose  deaths   by  removing  the  fear  of  arrest  as  a  barrier  to  seeking   emergency  medical  assistance.      
  • 23. 911  Good  Samaritan     893.21  Drug-­‐related  overdoses;  medical  assistance;  immunity  from   prosecu6on.   •  (1)  A  person  ac7ng  in  good  faith  who  seeks  medical  assistance  for  an  individual   experiencing  a  drug-­‐related  overdose  may  not  be  charged,  prosecuted,  or   penalized  pursuant  to  this  chapter  for  possession  of  a  controlled  substance  if  the   evidence  for  possession  of  a  controlled  substance  was  obtained  as  a  result  of  the   person’s  seeking  medical  assistance.   •  (2)  A  person  who  experiences  a  drug-­‐related  overdose  and  is  in  need  of  medical   assistance  may  not  be  charged,  prosecuted,  or  penalized  pursuant  to  this  chapter   for  possession  of  a  controlled  substance  if  the  evidence  for  possession  of  a   controlled  substance  was  obtained  as  a  result  of  the  overdose  and  the  need  for   medical  assistance.   •  (3)  Protec7on  in  this  sec7on  from  prosecu7on  for  possession  offenses  under  this   chapter  may  not  be  grounds  for  suppression  of  evidence  in  other  criminal   prosecu7ons.   •  This  act  shall  take  effect  October  1,  2012.  
  • 24. •  Collec7ng  extensive  demographic  and   circumstan7al  data  from  each  overdose  death   inves7ga7on.   •  Designing  a  prac7cal  overdose  death   database.   •   Exposing  overdose  correla7ons  and  trends.    
  • 25. Case  Examina6ons           •  353  overdose  death  cases   •  Palm  Beach  County,  Florida     •  Selected  by  chronological  occurrence     •  Data  derived  from:     Police  and  paramedic  reports         Autopsy  and  toxicology  findings     Family  and  friend  interviews       Medical  records        
  • 26.
  • 27.
  • 28.
  • 29. Decedents’  Average  Age   40.08  Years  
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38. •  White   •  Male   •  Approximately  40  years  old   •  High  School  Diploma  or  GED   •  Employed  
  • 39. •  History  of  substance  abuse   •  History  of  drug  related  arrests   •  History  of  substance  abuse  treatment   •  History  of  mental  health  treatment   •  History  of  non  fatal  drug  overdose   •  Under  physician’s  care  at  7me  of  death  
  • 40. •  Died  at  home   •  Discovered  by  family  member   •  Last  act  is  sleeping   •  Found  unconscious   •  Others  present  at  death  scene   •  Other  recognized  distress   •  Died  from  accidental  mul7ple  drug  toxicity   •  Most  likely  combina7ons  are  alprazolam,   oxycodone,  cocaine,  and  methadone.  
  • 41. Detec7ve  Gary  Mar7n     Violent  Crimes  Division  –  Homicide  Unit   Palm  Beach  County  Sheriff’s  Office     West  Palm  Beach,  Fl  33406   561-­‐688-­‐4058   mar7ng@pbso.org   Or     Gary  Mar7n,  Ed.D.   Associate  Dean  For  Student  Life   Lynn  University     Boca  Raton,  Fl  33431   561-­‐237-­‐7157   gmar7n@lynn.edu    
  • 42. Two  Unique  Approaches   April  2  –  4,  2013   Omni  Orlando  Resort     at  ChampionsGate  
  • 43. Learning  Objec6ves   •  1.    Outline  inves7ga7ve  priori7es  in  building  an                      overdose  death  prosecu7on.   •  2.    State  the  benefit  of  building  strategic                      coopera7on  between  federal  and  state  law                    enforcement  agencies.   •  3.    Demonstrate  how  law  enforcement  can  work            together  with  community  preven7on                                      programs  in  inves7ga7ons.  
  • 45. Controlled  Substances  Act  covers   overdose  deaths   21  USC  841(A)(1):    1.  Knowing  distribu7on  of  controlled                          substance                2.  Death  results  from  use  of  controlled                                                          substance        21  USC  846:                1.  Two  or  more  people  must  conspire  to                        distribute  a  controlled  substance              2.  Death  results  from  use  of  controlled                          substance  
  • 46. Inves7ga7ve  Priori7es   What caused the death? Who did it? •  Medical  examiner’s  report  essen7al  –   •  Witnesses  who  observed  drug   work  to  develop  rela7onships  with   distribu7on  to  the  deceased?   coroners   •  For  prescrip7on  overdoses,  tracking  the   •  Toxicology  report  helpful,  but  not   disposi7ve   paper  trail  is  useful   •  Do  NOT  have  to  prove  intent  to  kill,   •  Standard  drug  inves7ga7ons  is   recklessness,  foreseeability,  or  other   important  parallel   mental  state  rela7ve  to  the  death     •  The  element  that  must  be  proven  is   “Did  death  result  from  the  use  of  the   controlled  substance?”   •  Distributed  drug  does  not  have  to  be   exclusive  or  primary  cause  of  death,   only  had  to  have  played  a  part.  
  • 47. “Tradi7onal”  TARGETS   Sponsors,  Brokers,  Direct  Distributors   •  Developing  sources  of   informa7on  /  cooperators  key     •  Establish  rela7onships  between   targets  rela7ve  to  date  of   distribu7on   •  Was  target  in  the  chain  of   distribu7on  that  led  to  the  death   •  Tracking  the  line  from  the  end   user  to  the  drug  source  reveals   poten7al  targets    (All  in  the  chain   are  poten7al  defendants  as  long   as  distribu7on  to  end  user    was   reasonably  foreseeable)  
  • 48.  POTENTIAL  TARGETS   Doctors  /  Pharmacists   •  Need  to  show  target  prescribed  /   filled  medica7on  without  legi7mate   medical  purpose  outside  the  usual   course  of  professional  treatment     •  PaJern  of  pa7ents  help  to  establish   unlawful  distribu7on     •  Cash  only  clientele   •  Superficial  examina7ons   •  Expert  review  of  records   •  Cooperators  beneficial   •  Conspiratorial  rela7onship  between   providers  (warning  pa7ents  where   to  or  not  to  fill  scripts)  
  • 49. “Death  Resul7ng”  Penal7es    Statutory  Penal6es   Sentencing  Guidelines        21  USC  841(b)(1)(A)-­‐(C)   U.S.S.G.  §  2D1.1   •  Mandatory  Minimum  20  years   •  Deaths  from  Schedule  I  or  II  with  prior   with  Life  max   convic7on  for  trafficking  with  similar   drug  is  43  (360  –  life)   •  Applies  to  all  Schedule  I  and  II   •  No  prior  convic7on  is  38  (235-­‐293)   Controlled  Substances   (oxycodone,  methadone,  etc.)   •  Deaths  from  Schedule  III  and  IV  (ie:   hydrocodone,  alprazolam)  start  at  30   (97-­‐121)  with  prior  convic7on  and  26   (63-­‐78)  without  convic7on   •  All  ranges  assume  no  criminal  history   •  Ex:  Criminal  History  I  with  a  38   (235-­‐293)  is  (360  to  life)  with  a   Criminal  History  VI  
  • 50. United  States  v.  McIntosh   DEA  inves6ga6on  with  State     partnerships   Result  ?   •  What  made  it  work?   •  McIntosh  sentenced  to  327   •  First  responders  treated  call  as  a   months  for  distribu7on  resul7ng   crime  scene  vs.  an  accident     in  death  (guideline  range  of   •  Autopsy  that  established  oxycodone   292-­‐327)  Lowest  criminal  history   as  a  contribu7ng  factor  in  the  death   category   •  DEA  later  implicated  McIntosh  in  a   Who  collaborated?   large  oxycodone  conspiracy  through   •  Kentucky  State  Police   cooperator  statements  and  local  law   •  Local  Law  Enforcement   enforcement’s  street  level  buys     •  Crucial  leads  in  the  inves7ga7ve   •  County  Coroner   report  from  10  months  prior   •  State  Medical  Examiner   •  Knew  the  Who,  What,  When  and   •  DEA   Where  and  it  was  documented  
  • 51. Benefits  to  “death  resul7ng”   prosecu7ons   “Tradi6onal”  Drug  Dealers     “Professional”  Drug  Dealers   •  Dealing  is  ul7mately  a  decision   •  Doctors,  Pharmacists,  etc.   •  “The  nega7ve  has  to  outweigh  the   •  Enormous  profit  margins  for  pain  clinic   posi7ve”   owners,  doctors,  pharmacists   •  Reality  is  Rx  diversion  is  a  profitable   •  $100,000  cash  in  one  day,  for  example   revenue  plan  for  many   •  Violate  your  duty,  responsible  for  the   •  These  prosecu7ons  send  a  simple,   consequence   powerful  message     •  Given  the  harm  produced  from   prescrip7on  diversion,  must  target   •  Distribute  prescrip7on  drugs,  you  will   those  with  “keys  to  the  castle”   be  held  responsible  for  the   •  Treats  the  source  =  to  a  drug  dealer   consequence    
  • 52. Ques7ons/Comments   Jason  D.  Parman   United  States  AJorneys  Office   Eastern  District  of  Kentucky   606-­‐864-­‐5523    Ext.  117   Jason.Parman@usdoj.gov